Potential of chromosomal and matrix-based comparative genomic hybridization for molecular diagnostics in lymphomas

Ann Hematol. 2001:80 Suppl 3:B35-7. doi: 10.1007/pl00022785.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study
  • Multicenter Study
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Chromosome Aberrations
  • Chromosomes, Human / genetics
  • Chromosomes, Human / ultrastructure
  • Cyclophosphamide / administration & dosage
  • DNA, Neoplasm / genetics
  • Doxorubicin / administration & dosage
  • Etoposide / administration & dosage
  • Humans
  • Life Tables
  • Lymphoma, Non-Hodgkin / diagnosis
  • Lymphoma, Non-Hodgkin / drug therapy
  • Lymphoma, Non-Hodgkin / genetics*
  • Lymphoma, Non-Hodgkin / mortality
  • Lymphoma, Non-Hodgkin / pathology
  • Metaphase
  • Nucleic Acid Hybridization / methods*
  • Oligonucleotide Array Sequence Analysis
  • Prednisolone / administration & dosage
  • Prednisone / administration & dosage
  • Prospective Studies
  • Survival Analysis
  • Vincristine / administration & dosage

Substances

  • DNA, Neoplasm
  • Vincristine
  • Etoposide
  • Doxorubicin
  • Cyclophosphamide
  • Prednisolone
  • Prednisone

Supplementary concepts

  • CHOEP protocol
  • CHOP protocol